TheTechno Optimist.

StoryFunding9 Mar 2022

Colossal raises $60M Series A led by Thomas Tull and At One Ventures

Colossal Biosciences

Colossal raised a $60M Series A led by investor Thomas Tull and At One Ventures, bringing total funding to $75M six months after launch. It said tools built on the way to a mammoth, such as artificial wombs and stem cell lines, could be sold for other uses.

Read the original · Press Biotech

More on Colossal Biosciences

Colossal reportedly in talks to raise at a $20B-$30B valuationJul 2026
Colossal hatches 26 chicks from artificial egg using silicone membrane system in breakthrough for de-extinction19 May 2026
Colossal achieves near-complete thylacine genome with 99.9% accuracy and 300+ edits in dunnart cells22 Apr 2026
UAE puts $60M into Colossal to build a frozen-cell 'BioVault' for endangered species in Dubai3 Feb 2026
Colossal Biosciences raises $120M for dodo de-extinction with breakthrough in pigeon primordial germ cells17 Sep 2025
Colossal adds $120M to its Series C, reaching a $10.3B valuation, and grows pigeon germ cells toward a dodo17 Sep 2025